Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?

Zsolt Mezei,1 Daniel Bereczki,1,2 Lilla Racz,1 Laszlo Csiba,1 Tunde Csepany11Department of Neurology, University of Debrecen, Debrecen, Hungary; 2Department of Neurology, Semmelweis University, Budapest, HungaryBackground: Decreased relapse rate and slower disease progression have been reported with...

Full description

Bibliographic Details
Main Authors: Mezei Z, Bereczki D, Racz L, Csiba L, Csepany T
Format: Article
Language:English
Published: Dove Medical Press 2012-10-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/can-a-physician-predict-the-clinical-response-to-first-line-immunomodu-a11330